FDA NDC Directory · JSON-LD · Markdown

spironolactone

NDC 31722-691 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218085
Dosage form / routeSUSPENSION · ORAL
Active ingredientsSPIRONOLACTONE (25 mg/5mL)
Marketing started20250221
Package count2

External sources

Source: openFDA. Public-domain (CC0).